BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.

Saved in:
Bibliographic Details
Title: BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.
Authors: Imianowski CJ; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Whiteside SK; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Lozano T; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Evans AC; Department of Pathology, University of Cambridge, Cambridge, UK., Benson JD; Department of Pathology, University of Cambridge, Cambridge, UK., Courreges CJF; Department of Pathology, University of Cambridge, Cambridge, UK., Sadiyah F; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Lau CM; Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY.; Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY., Zandhuis ND; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Grant FM; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Schuijs MJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Vardaka P; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Kuo P; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Soilleux EJ; Department of Pathology, University of Cambridge, Cambridge, UK., Yang J; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK., Sun JC; Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY.; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY., Kurosaki T; Laboratory of Lymphocyte Differentiation, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.; Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan., Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK., Halim TYF; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire, UK.
Source: The Journal of experimental medicine [J Exp Med] 2022 Dec 05; Vol. 219 (12). Date of Electronic Publication: 2022 Sep 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20211476